| Element List | Explanation |
|---|---|
| Introduction | Middle East Healthcare Company (Saudi German Health) announces the Board of Directors’ decision to recommend to the Extraordinary General Assembly the approval of purchasing the Company’s shares, up to a maximum of 4,602,000 shares (Four million six hundred and two thousand shares), representing (5%) of the total issued shares, for the purpose of holding them as treasury shares. |
| Board of director’s recommendation date | 2026-02-24 Corresponding to 1447-09-07 |
| Purpose of Purchase | Keeping them as treasury shares |
| Purpose of Purchase (If the Purpose to Keep the Shares as Treasury Shares) | The board of directors believes that the share price in the market is less than its fair value. |
| Number of Shares to be Bought | 4602000 |
| Shares Class and type | Ordinary shares |
| Method of Financing the Purchasing Process | Company's own resources or bank facilities |
| Current Percentage of the Treasury Shares at the Company out of the Total Class of Shares Purchased | 0% |
| Approvals and Meeting the Conditions of Financial Appropriateness | The Board of Directors’ recommendation will be presented to the upcoming Extraordinary General Assembly for approval, in accordance with paragraph (4) of Article (17) of the Implementing Regulations of the Companies Law for Listed Joint Stock Companies. |
The Company will also comply with all financial solvency requirements set out in paragraph (3) of Article (17) of the same Regulations, and a report issued by the Company’s external auditor on the Company’s financial solvency will be submitted in accordance with the requirements of this paragraph.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.